The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way

See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.

MEDP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $245,487,557.59

Medpace Insider Trading History Chart

Medpace Share Price & Price History

^$387.61

▼ -14.49 (-3.60%)

As of 05/8/2024 01:00 AM ET

Days: 30 | 90 | 365

AI “wealth window” is closing June 25th

From Paradigm Press | Ad

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

Medpace Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/29/2024	August J. Troendle	CEO	Sell	15,102	$400.69	$6,051,220.38	791,541
3/15/2024	Susan E. Burwig	VP	Sell	102	$403.00	$41,106.00	15,181
3/14/2024	Ashley M. Keating	Director	Sell	250	$409.87	$102,467.50	250
3/8/2024	August J. Troendle	CEO	Sell	25,000	$408.71	$10,217,750.00	4,733,019
3/6/2024	August J. Troendle	CEO	Sell	100,000	$412.98	$41,298,000.00	4,833,019
2/20/2024	Medpace Investors, Llc	Major Shareholder	Sell	13,988	$386.39	$5,404,823.32	5,525,959
2/16/2024	Medpace Investors, Llc	Major Shareholder	Sell	50,000	$391.75	$19,587,500.00	5,539,947
12/14/2023	Susan E. Burwig	VP	Sell	10,391	$304.15	$3,160,422.65	17,292
12/1/2023	Medpace Investors, Llc	Major Shareholder	Sell	24,039	$273.26	$6,568,897.14	5,589,947
11/30/2023	August J. Troendle	CEO	Sell	7,871	$272.18	$2,142,328.78	5,613,986
11/29/2023	Medpace Investors, Llc	Major Shareholder	Sell	21,257	$272.66	$5,795,933.62	5,621,857
11/28/2023	August J. Troendle	CEO	Sell	21,833	$273.66	$5,974,818.78	5,643,114
11/27/2023	Medpace Investors, Llc	Major Shareholder	Sell	25,000	$276.10	$6,902,500.00	5,664,947
11/22/2023	August J. Troendle	CEO	Sell	25,000	$277.81	$6,945,250.00	5,689,947
11/16/2023	August J. Troendle	CEO	Sell	17,000	$281.61	$4,787,370.00	5,839,947
11/15/2023	Medpace Investors, Llc	Major Shareholder	Sell	33,000	$283.42	$9,352,860.00	5,856,947
11/14/2023	August J. Troendle	CEO	Sell	25,000	$283.11	$7,077,750.00	5,889,947
9/21/2023	August J. Troendle	CEO	Sell	61,655	$244.27	$15,060,466.85	5,914,947
9/20/2023	Medpace Investors, Llc	Major Shareholder	Sell	65,653	$255.48	$16,773,028.44	5,976,602
9/19/2023	August J. Troendle	CEO	Sell	137,379	$259.66	$35,671,831.14	6,042,255
9/18/2023	Medpace Investors, Llc	Major Shareholder	Sell	53,385	$274.76	$14,668,062.60	6,179,634
8/14/2023	Robert O. Kraft	Director	Sell	13,782	$265.67	$3,661,463.94	188
7/31/2023	Kevin M. Brady	CFO	Sell	7,000	$255.00	$1,785,000.00	6,000
7/27/2023	Stephen P. Ewald	General Counsel	Sell	21,850	$254.39	$5,558,421.50	14,854
6/8/2023	August J. Troendle	CEO	Sell	49,347	$220.85	$10,898,284.95	6,233,019
4/25/2023	August J. Troendle	CEO	Sell	31,648	$221.83	$7,020,475.84	6,451,371
10/27/2022	Stephen P. Ewald	General Counsel	Sell	6,500	$220.53	$1,433,445.00	14,854
9/22/2022	Medpace Investors, Llc	Major Shareholder	Buy	57,426	$154.59	$8,877,485.34	6,483,019
9/21/2022	August J. Troendle	CEO	Buy	94,119	$161.63	$15,212,453.97	6,425,593
9/19/2022	Medpace Investors, Llc	Major Shareholder	Buy	94,119	$153.48	$14,445,384.12	6,237,355
9/15/2022	August J. Troendle	CEO	Buy	62,516	$153.11	$9,571,824.76	6,080,720
9/13/2022	Medpace Investors, Llc	Major Shareholder	Buy	62,516	$157.12	$9,822,513.92	5,955,688
9/12/2022	August J. Troendle	CEO	Buy	62,515	$167.58	$10,476,263.70	5,893,172
9/8/2022	August J. Troendle	CEO	Buy	56,557	$157.65	$8,916,211.05	5,774,100
7/18/2022	August J. Troendle	CEO	Buy	8,330	$145.00	$1,207,850.00	5,513,639
7/14/2022	August J. Troendle	CEO	Buy	22,290	$144.59	$3,222,911.10	5,505,309
1/4/2022	August J. Troendle	CEO	Sell	3,338	$213.44	$712,462.72
12/29/2021	August J. Troendle	CEO	Sell	16,750	$220.16	$3,687,680.00
12/28/2021	Medpace Investors, Llc	Major Shareholder	Sell	24,118	$222.18	$5,358,537.24
12/27/2021	August J. Troendle	CEO	Sell	39,171	$226.11	$8,856,954.81
12/23/2021	Medpace Investors, Llc	Major Shareholder	Sell	22,830	$223.19	$5,095,427.70
12/22/2021	August J. Troendle	CEO	Sell	38,960	$220.50	$8,590,680.00
12/21/2021	Medpace Investors, Llc	Major Shareholder	Sell	18,133	$215.17	$3,901,677.61
12/20/2021	August J. Troendle	CEO	Sell	22,734	$212.57	$4,832,566.38
12/17/2021	August J. Troendle	CEO	Sell	30,605	$213.59	$6,536,921.95
12/16/2021	Medpace Investors, Llc	Major Shareholder	Sell	5,959	$210.22	$1,252,700.98
12/15/2021	August J. Troendle	CEO	Sell	2,424	$210.28	$509,718.72
12/10/2021	Medpace Investors, Llc	Major Shareholder	Sell	309	$210.20	$64,951.80
12/9/2021	August J. Troendle	CEO	Sell	14,994	$212.13	$3,180,677.22
12/8/2021	Medpace Investors, Llc	Major Shareholder	Sell	15,871	$212.89	$3,378,777.19
12/7/2021	August J. Troendle	CEO	Sell	18,520	$211.78	$3,922,165.60
12/3/2021	Medpace Investors, Llc	Major Shareholder	Sell	400	$211.48	$84,592.00
11/30/2021	Medpace Investors, Llc	Major Shareholder	Sell	197	$210.29	$41,427.13
11/29/2021	August J. Troendle	CEO	Sell	12,115	$212.10	$2,569,591.50
11/26/2021	August J. Troendle	CEO	Sell	15,071	$210.99	$3,179,830.29
11/24/2021	August J. Troendle	CEO	Sell	14,578	$213.26	$3,108,904.28
11/3/2021	Tom C. King	Director	Sell	176	$226.63	$39,886.88
11/2/2021	Kevin M. Brady	CFO	Sell	1,250	$226.50	$283,125.00
10/26/2021	Ashley M. Keating	Director	Sell	2,000	$210.00	$420,000.00
10/26/2021	Stephen P. Ewald	General Counsel	Sell	10,000	$209.13	$2,091,300.00
9/1/2021	Medpace Investors, Llc	Major Shareholder	Sell	14,304	$186.29	$2,664,692.16	6,002,344
8/31/2021	August J. Troendle	CEO	Sell	12,675	$182.04	$2,307,357.00	706,643
8/25/2021	Medpace Investors, Llc	Major Shareholder	Sell	7,622	$180.54	$1,376,075.88	6,039,561
8/5/2021	August J. Troendle	CEO	Sell	556	$180.04	$100,102.24
8/4/2021	Ashley M. Keating	Director	Sell	1,000	$178.00	$178,000.00
7/29/2021	Tom C. King	Director	Sell	226	$175.74	$39,717.24
7/27/2021	Medpace Investors, Llc	Major Shareholder	Sell	131	$180.93	$23,701.83
7/26/2021	August J. Troendle	CEO	Sell	15,209	$181.47	$2,759,977.23
7/23/2021	August J. Troendle	CEO	Sell	18,882	$181.21	$3,421,607.22
7/22/2021	Medpace Investors, Llc	Major Shareholder	Sell	8,516	$180.63	$1,538,245.08	6,109,621
7/21/2021	August J. Troendle	CEO	Sell	9,206	$182.42	$1,679,358.52	706,643
7/20/2021	Medpace Investors, Llc	Major Shareholder	Sell	10,176	$183.06	$1,862,818.56
7/19/2021	August J. Troendle	CEO	Sell	1,442	$181.11	$261,160.62	6,138,961
7/16/2021	Medpace Investors, Llc	Major Shareholder	Sell	12,454	$182.83	$2,276,964.82	6,138,961
7/15/2021	August J. Troendle	CEO	Sell	13,697	$181.88	$2,491,210.36
7/14/2021	Medpace Investors, Llc	Major Shareholder	Sell	11,026	$182.63	$2,013,678.38	6,165,112
7/13/2021	August J. Troendle	CEO	Sell	13,050	$182.96	$2,387,628.00	706,643
7/12/2021	Medpace Investors, Llc	Major Shareholder	Sell	10,540	$183.22	$1,931,138.80	6,189,188
7/9/2021	August J. Troendle	CEO	Sell	12,597	$183.34	$2,309,533.98
7/8/2021	Medpace Investors, Llc	Major Shareholder	Sell	3,951	$180.18	$711,891.18	6,212,325
7/7/2021	August J. Troendle	CEO	Sell	4,574	$180.33	$824,829.42	706,643
7/6/2021	Medpace Investors, Llc	Major Shareholder	Sell	4,729	$180.58	$853,962.82	706,643
6/29/2021	August J. Troendle	CEO	Sell	4,926	$181.11	$892,147.86	706,643
6/28/2021	Medpace Investors, Llc	Major Shareholder	Sell	8,225	$181.15	$1,489,958.75	6,242,524
6/25/2021	Medpace Investors, Llc	Major Shareholder	Sell	10,846	$180.56	$1,958,353.76	6,242,524
6/23/2021	August J. Troendle	CEO	Sell	1,837	$180.79	$332,111.23	706,643
6/22/2021	Medpace Investors, Llc	Major Shareholder	Sell	12,133	$182.31	$2,211,967.23	6,267,340
6/21/2021	August J. Troendle	CEO	Sell	9,345	$181.86	$1,699,481.70	706,643
6/18/2021	August J. Troendle	CEO	Sell	1,261	$180.43	$227,522.23	706,643
6/17/2021	Medpace Investors, Llc	Major Shareholder	Sell	8,927	$181.20	$1,617,572.40	6,277,946
6/16/2021	August J. Troendle	CEO	Sell	17,413	$181.13	$3,154,016.69	706,643
6/15/2021	Medpace Investors, Llc	Major Shareholder	Sell	15,706	$182.00	$2,858,492.00	6,304,286
6/14/2021	Susan E. Burwig	VP	Sell	15,000	$178.96	$2,684,400.00	77,405

READ THIS – If You Missed Out On The AI Boom

From Banyan Hill Publishing | Ad

Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”

Click on Adam's shiny forehead for more details.

SEC Filings (Institutional Ownership Changes) for Medpace (NASDAQ:MEDP)

77.98% of Medpace stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Medpace Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/8/2024	Sheets Smith Wealth Management	3,919	$1.58M	0.2%	-4.6%	0.013%
5/8/2024	ProShare Advisors LLC	3,337	$1.35M	0.0%	+3.1%	0.011%
5/8/2024	US Bancorp DE	4,816	$1.95M	0.0%	-8.6%	0.016%
5/8/2024	Russell Investments Group Ltd.	37,477	$15.15M	0.0%	-6.1%	0.121%
5/8/2024	QRG Capital Management Inc.	10,553	$4.27M	0.1%	+322.5%	0.034%
5/8/2024	Inspire Investing LLC	910	$0.37M	0.0%	-29.6%	0.003%
5/8/2024	Donoghue Forlines LLC	3,978	$1.61M	0.5%	-19.2%	0.013%
5/7/2024	Meeder Advisory Services Inc.	568	$0.23M	0.0%	N/A	0.002%
5/7/2024	Sei Investments Co.	135,649	$54.82M	0.1%	+12.7%	0.438%
5/7/2024	Redmond Asset Management LLC	3,118	$1.26M	0.4%	-1.0%	0.010%
5/7/2024	GW Henssler & Associates Ltd.	555	$0.22M	0.0%	N/A	0.002%
5/7/2024	Swiss National Bank	48,400	$19.56M	0.0%	+0.4%	0.156%
5/7/2024	ClariVest Asset Management LLC	6,251	$2.53M	0.3%	-60.4%	0.020%
5/7/2024	Lisanti Capital Growth LLC	3,590	$1.45M	0.4%	-1.5%	0.012%
5/7/2024	Oppenheimer Asset Management Inc.	38,630	$15.61M	0.2%	-13.9%	0.125%
5/7/2024	SG Americas Securities LLC	15,002	$6.06M	0.0%	+351.5%	0.048%
5/7/2024	Empowered Funds LLC	15,353	$6.21M	0.1%	+248.0%	0.050%
5/6/2024	Quantbot Technologies LP	2,315	$0.94M	0.1%	-7.7%	0.007%
5/6/2024	Envestnet Portfolio Solutions Inc.	3,571	$1.44M	0.0%	-10.9%	0.012%
5/6/2024	Davidson Capital Management Inc.	7,424	$3M	1.0%	-7.6%	0.024%
5/6/2024	Gallacher Capital Management LLC	1,091	$0.44M	0.2%	-4.1%	0.004%
5/6/2024	Advisory Services Network LLC	17,156	$6.93M	0.2%	-1.8%	0.055%
5/6/2024	Manchester Capital Management LLC	507	$0.21M	0.0%	+50,600.0%	0.002%
5/6/2024	Mitchell Capital Management Co.	18,075	$7.31M	1.4%	+3.7%	0.058%
5/6/2024	Texas Permanent School Fund Corp	20,409	$8.25M	0.1%	+1.3%	0.066%
5/3/2024	Larson Financial Group LLC	8,305	$3.36M	0.3%	+1.3%	0.027%
5/3/2024	Chevy Chase Trust Holdings LLC	12,184	$4.92M	0.0%	-0.3%	0.039%
5/3/2024	BI Asset Management Fondsmaeglerselskab A S	11,646	$4.71M	0.1%	-17.1%	0.038%
5/3/2024	RiverPark Advisors LLC	554	$0.22M	0.2%	+544.2%	0.002%
5/3/2024	Central Pacific Bank Trust Division	1,290	$0.51M	0.1%	N/A	0.004%
5/2/2024	Suncoast Equity Management	1,418	$0.57M	0.1%	+5.6%	0.005%
5/2/2024	Chase Investment Counsel Corp	8,781	$3.55M	1.3%	-9.2%	0.028%
5/2/2024	Mutual of America Capital Management LLC	13,895	$5.62M	0.1%	-3.9%	0.045%
5/2/2024	FORA Capital LLC	5,499	$2.22M	0.2%	N/A	0.018%
5/2/2024	Daiwa Securities Group Inc.	1,696	$0.69M	0.0%	+391.6%	0.005%
5/2/2024	Hardy Reed LLC	867	$0.35M	0.0%	-16.1%	0.003%
5/2/2024	Nordea Investment Management AB	67,555	$27.25M	0.0%	-4.4%	0.218%
5/2/2024	Fidelis Capital Partners LLC	76	$31K	0.0%	N/A	0.000%
5/2/2024	Schulhoff & Co. Inc.	2,326	$0.94M	0.4%	+3.4%	0.008%
5/2/2024	Hanlon Investment Management Inc.	2,336	$0.94M	0.3%	-7.9%	0.008%
5/1/2024	Wakefield Asset Management LLLP	2,617	$1.06M	0.4%	-27.4%	0.008%
5/1/2024	Capstone Investment Advisors LLC	1,176	$0.48M	0.0%	N/A	0.004%
5/1/2024	Janney Montgomery Scott LLC	7,630	$3.08M	0.0%	+7.5%	0.025%
5/1/2024	BNP Paribas Financial Markets	54,291	$21.94M	0.0%	+110.6%	0.175%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	12,815	$5.18M	0.0%	N/A	0.041%
5/1/2024	Smith Group Asset Management LLC	106,623	$43.09M	2.5%	-6.4%	0.344%
5/1/2024	Sequoia Financial Advisors LLC	497	$0.20M	0.0%	-74.7%	0.002%
5/1/2024	Diversify Advisory Services LLC	1,641	$0.65M	0.0%	N/A	0.005%
5/1/2024	Private Advisor Group LLC	1,065	$0.43M	0.0%	+10.1%	0.003%
4/30/2024	Findlay Park Partners LLP	223,300	$90.25M	0.8%	N/A	0.721%
4/30/2024	Retirement Systems of Alabama	62,183	$25.13M	0.1%	+0.1%	0.201%
4/30/2024	Norden Group LLC	2,670	$1.08M	0.1%	-46.7%	0.009%
4/30/2024	Van ECK Associates Corp	11,201	$4.53M	0.0%	+36.5%	0.036%
4/30/2024	Harel Insurance Investments & Financial Services Ltd.	6,545	$2.65M	0.1%	+26.6%	0.021%
4/30/2024	Argent Capital Management LLC	15,850	$6.41M	0.2%	+2.3%	0.051%
4/30/2024	Claret Asset Management Corp	584	$0.24M	0.0%	N/A	0.002%
4/29/2024	Commonwealth Equity Services LLC	4,308	$1.74M	0.0%	+32.4%	0.014%
4/29/2024	Principal Financial Group Inc.	88,189	$35.64M	0.0%	-12.6%	0.285%
4/29/2024	Benjamin F. Edwards & Company Inc.	781	$0.32M	0.0%	+5.3%	0.003%
4/29/2024	Meritage Portfolio Management	2,733	$1.11M	0.1%	-8.5%	0.009%
4/29/2024	China Universal Asset Management Co. Ltd.	5,882	$2.38M	0.3%	+65.5%	0.019%
4/26/2024	McGuire Investment Group LLC	45,049	$18.21M	2.7%	+0.5%	0.145%
4/26/2024	UMB Bank n.a.	106	$43K	0.0%	-62.5%	0.000%
4/26/2024	Riverbridge Partners LLC	606,250	$245.02M	3.0%	-11.4%	1.957%
4/26/2024	Yousif Capital Management LLC	10,858	$4.39M	0.0%	-3.8%	0.035%
4/25/2024	Shaker Investments LLC OH	10,253	$4.14M	1.8%	-13.8%	0.033%
4/25/2024	Fielder Capital Group LLC	618	$0.25M	0.1%	N/A	0.002%
4/25/2024	Zurcher Kantonalbank Zurich Cantonalbank	6,526	$2.64M	0.0%	-5.4%	0.021%
4/24/2024	CENTRAL TRUST Co	753	$0.30M	0.0%	-21.1%	0.002%
4/24/2024	HMS Capital Management LLC	741	$0.30M	0.2%	N/A	0.002%
4/24/2024	Dakota Wealth Management	7,247	$2.93M	0.1%	+1.4%	0.023%
4/24/2024	Assenagon Asset Management S.A.	108,522	$43.86M	0.1%	+27.6%	0.350%
4/23/2024	Bell Bank	3,008	$1.22M	0.1%	-10.3%	0.010%
4/23/2024	Rice Hall James & Associates LLC	121,885	$49.26M	2.8%	-4.5%	0.393%
4/23/2024	Louisiana State Employees Retirement System	6,700	$2.71M	0.1%	+3.1%	0.022%
4/23/2024	Origin Asset Management LLP	509	$0.21M	0.1%	N/A	0.002%
4/23/2024	Amalgamated Bank	12,964	$5.24M	0.0%	-22.1%	0.042%
4/23/2024	Nations Financial Group Inc. IA ADV	1,802	$0.73M	0.1%	+11.4%	0.006%
4/23/2024	Fifth Third Bancorp	2,390	$0.97M	0.0%	-9.9%	0.008%
4/23/2024	Duncker Streett & Co. Inc.	321	$0.13M	0.0%	N/A	0.001%
4/23/2024	Arcadia Investment Management Corp MI	101	$41K	0.0%	+40.3%	0.000%
4/22/2024	Raymond James & Associates	48,384	$19.55M	0.0%	+2.9%	0.156%
4/19/2024	Arcus Capital Partners LLC	965	$0.39M	0.1%	+15.7%	0.003%
4/19/2024	Norden Group LLC	29,480	$11.91M	0.1%	+488.0%	0.095%
4/19/2024	Lifestyle Asset Management Inc.	3,740	$1.51M	0.9%	-6.2%	0.012%
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	1,756	$0.71M	0.0%	-14.6%	0.006%
4/19/2024	Handelsinvest Investeringsforvaltning	770	$0.31M	0.1%	-34.1%	0.002%
4/18/2024	Wasatch Advisors LP	974,415	$393.81M	2.1%	-17.9%	3.145%
4/18/2024	State of Michigan Retirement System	5,699	$2.30M	0.0%	+1.8%	0.018%
4/18/2024	Allspring Global Investments Holdings LLC	10,340	$4.18M	0.0%	+16.3%	0.033%
4/18/2024	Congress Wealth Management LLC DE	28,752	$11.62M	0.2%	-11.3%	0.093%
4/18/2024	Diversified Trust Co	1,772	$0.72M	0.0%	-25.5%	0.006%
4/16/2024	Ausbil Investment Management Ltd	6,974	$2.78M	1.4%	+27.5%	0.023%
4/15/2024	Future Financial Wealth Managment LLC	500	$0.20M	0.2%	N/A	0.002%
4/15/2024	Sunbelt Securities Inc.	514	$0.21M	0.0%	+24.5%	0.002%
4/12/2024	Annex Advisory Services LLC	41,438	$16.75M	0.6%	+8.6%	0.134%
4/12/2024	Bridge City Capital LLC	18,556	$7.50M	2.7%	-15.8%	0.060%
4/12/2024	FCF Advisors LLC	9,769	$3.95M	1.0%	-0.4%	0.032%
4/11/2024	Rheos Capital Works Inc.	24,601	$9.94M	0.5%	N/A	0.079%
4/11/2024	Congress Asset Management Co. MA	155,406	$62.81M	0.4%	+1.3%	0.502%

Data available starting January 2016

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Today's Range

Now: $387.61

$386.72

$402.00

50 Day Range

MA: $397.69

$372.00

$413.31

52 Week Range

Now: $387.61

$197.39

$421.00

Volume

250,833 shs

Average Volume

248,902 shs

Market Capitalization

$12.01 billion

P/E Ratio

39.51

Dividend Yield

N/A

Beta

1.4

Who are the company insiders with the largest holdings of Medpace?: Medpace's top insider investors include:
Medpace Investors, Llc (Major Shareholder)
August J Troendle (CEO)
Susan E Burwig (VP)
Stephen P Ewald (General Counsel)
Kevin M Brady (CFO)
Ashley M Keating (Director)
Robert O Kraft (Director)
Learn More about top insider investors at Medpace.
Who are the major institutional investors of Medpace?: Medpace's top institutional investors include:
Wasatch Advisors LP — 3.15%
Riverbridge Partners LLC — 1.96%
Los Angeles Capital Management LLC — 0.85%
Findlay Park Partners LLP — 0.72%
Congress Asset Management Co. MA — 0.50%
Sei Investments Co. — 0.44%
Learn More about top institutional investors of Medpace stock.
Which major investors are selling Medpace stock?: During the previous quarter, MEDP stock was sold by these institutional investors:
Wasatch Advisors LP
Riverbridge Partners LLC
Westwind Capital
Principal Financial Group Inc.
ClariVest Asset Management LLC
Smith Group Asset Management LLC
Oppenheimer Asset Management Inc.
Rice Hall James & Associates LLC
During the previous year, company insiders that have sold Medpace company stock include:
Medpace Investors, Llc (Major Shareholder)
August J Troendle (CEO)
Susan E Burwig (VP)
Stephen P Ewald (General Counsel)
Kevin M Brady (CFO)
Ashley M Keating (Director)
Robert O Kraft (Director)
Learn More investors selling Medpace stock.
Which major investors are buying Medpace stock?: Within the previous quarter, MEDP stock was purchased by institutional investors including:
Findlay Park Partners LLP
BNP Paribas Financial Markets
Rheos Capital Works Inc.
Norden Group LLC
Assenagon Asset Management S.A.
Sei Investments Co.
Mirae Asset Global Investments Co. Ltd.
SG Americas Securities LLC
In the previous year, these company insiders have bought Medpace stock:
Medpace Investors, Llc (Major Shareholder)
August J Troendle (CEO)
Learn More investors buying Medpace stock.